Frontlight ResearchEarly access
WithdrawnNo phase
Understanding the Impact of Drug Shortages on Oncology Care Delivery
Key facts
- Who runs it
- University of Rochester NCORP Research Base
- Where
- Minneapolis, Robbinsdale, Saint Paul, Spartanburg, and Winston-Salem, United StatesSee the 6 sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Jul 2018
- Ended
- 18 Jun 2025
- Type of study
- Observational
- Treatments tested
- Survey Administration
- Record updated
- 4 April 2025
- Why it stopped
- Study is not human subjects research.
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Be a primary affiliate or sub-affiliate of an NCORP community site or minority underserved (M/U) community site that is affiliated with the University of Rochester Cancer Center (URCC) NCORP Research Base; Practice sites must have a valid Cancer Therapy Evaluation Program (CTEP) identification number; Practice sites may or may not share a pharmacy
- Provide infusional chemotherapy treatment (either inpatient or outpatient)
Who cannot take part
- Practice sites that do not provide infusional chemotherapy
- Practices sites without valid CTEP identification (ID)
Where in United States
- Health Partners IncMinneapolis, United States
- Hennepin County Medical CenterMinneapolis, United States
- North Memorial Medical Health CenterRobbinsdale, United States
- Regions HospitalSaint Paul, United States
- Spartanburg Medical CenterSpartanburg, United States
- Southeast Clinical Oncology Research ProgramWinston-Salem, United States
About the trial
What the trial wants to find out
This trial studies the impact of drug shortages on oncology care delivery. Gathering information about cancer drug shortages over time may help researchers improve access to drugs during times of shortages.
The group in the trial
- Health Services Research (surveys about drug shortages)
At baseline, practice sites complete a Baseline Drug Shortage Survey and Pharmacy Baseline Survey; Drug Shortage Incident Reports are completed in real time as cancer care delivery problems occur; and the Quarterly Follow-Up Survey Number Treated Report every 3 months for one year (4 total).
Treatment: Survey Administration
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 4 April 2025